Establishing A Bespoke Outsourcing Arrangement With Hybrid FSP/FSO Partnerships

Outsourcing has become increasingly integral in the landscape of clinical trials, with drug developers relying on clinical research organizations (CROs) to navigate trial complexities and bolster their operational capacities. Various outsourcing models, such as bespoke functional service provider (FSP) and full-service outsourcing (FSO), offer flexibility in meeting diverse needs. A burgeoning hybrid outsourcing model, blending elements of FSP and FSO approaches, embraces agility to optimize clinical trial efficiency.

This white paper delves into:

• How the integration of FSP solutions enhances traditional FSO frameworks, forming a tailored hybrid FSP/FSO model that enhances overall clinical trial performance and addresses persistent operational challenges.
• The benefits of incorporating PPD™ FSP solutions into both new and existing FSO arrangements, providing drug developers with a customized approach that precisely aligns with their specific requirements.